Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-10
2010-10-05
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S577000
Reexamination Certificate
active
07807691
ABSTRACT:
The present invention provides a compound of the Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of Formula (I).
REFERENCES:
patent: 5411981 (1995-05-01), Gaillard-Kelly et al.
patent: 2004/0157859 (2004-08-01), Wu et al.
patent: WO 01/27107 (2001-04-01), None
patent: WO 2004/016576 (2004-02-01), None
patent: WO 2005/000795 (2005-01-01), None
RN 860759-80-4, retrieved from CAPLUS on Jun. 10, 2009.
Tucker, et al., “Nonsteroidal Antiandrogens. Synthesis and Structure-Activity Relationships of 3-Substituted Derivatives of 2-Hydroxypropionanilides,”Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 31, No. 5, pp. 954-959 (1988).
Elslager, et al., “Folate Antagonists. 3. 2,4-Diamino-6-(Heterocyclic)Quinazolines, a Novel Class of Antimetabolites with Potent Antimalarial and Antibacterial Activity,”Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 15, No. 8, pp. 827-836 (1972).
Gavardinas Konstantinos
Jadhav Prabhakar Kondaji
Stack Douglas Richard
Anderson Rebecca L
Eli Lilly and Company
Wilson Alexander
Young Shawquia
LandOfFree
Substituted N-arylpyrrolidines as selective androgen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-arylpyrrolidines as selective androgen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-arylpyrrolidines as selective androgen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4239957